Fundz

Aldeyra Therapeutics, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $25 Million

PUBLIC · ALDXFeb 11, 2019$10M of $25M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Feb 11, 2019)

Round Type

Venture

ConcordBiotechnologyHealth CareTherapeutics

Quick answer

Aldeyra Therapeutics raised $10 Million in a funding round, dated February 11, 2019. Aldeyra Therapeutics is based in Concord, Massachusetts, United States.

How much did Aldeyra Therapeutics raise?
Aldeyra Therapeutics raised $10 Million in a funding round on February 11, 2019.
What does Aldeyra Therapeutics do?
Aldeyra Therapeutics, Inc. is a biotechnology company focused on the development of novel therapies for immune-mediated diseases.
Where is Aldeyra Therapeutics based and how big is it?
Aldeyra Therapeutics is based in Concord, Massachusetts, United States. Fundz records about 17 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Aldeyra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Aldeyra Therapeutics, and when

A new round usually means Aldeyra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aldeyra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aldeyra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aldeyra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aldeyra Therapeutics

Location

Concord, Massachusetts, United States

About

Aldeyra Therapeutics, Inc. is a biotechnology company focused on the development of novel therapies for immune-mediated diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aldeyra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aldeyra Therapeutics's next move

See what Strategic adds

Aldeyra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.